I support COVID-19: a participatory action research project testing an innovative virtual support modality developed according to the model of compassionate communities in order to understand and prevent complicated mourning in the context of a pandemic

  • Funded by Canadian Institutes of Health Research (CIHR)
  • Total publications:239 publications

Grant number: Unknown

Grant search

Key facts

  • Disease

    COVID-19
  • start year

    2020
  • Known Financial Commitments (USD)

    $56,750.25
  • Funder

    Canadian Institutes of Health Research (CIHR)
  • Principal Investigator

    Unspecified Unspecified Unspecified
  • Research Location

    Canada
  • Lead Research Institution

    Université du Québec à Montréal
  • Research Priority Alignment

    N/A
  • Research Category

    Secondary impacts of disease, response & control measures

  • Research Subcategory

    Indirect health impacts

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Google translate: Public health measures to stem the spread of COVID-19 have tragically disrupted support for people at the end of life as well as the mourning process for their loved ones. To date, the particularities of mourning in the context of a pandemic have not been documented by any study. However, several writings lead to the conclusion that this context involves many factors likely to generate an increase in complicated bereavements. At the same time, the measures of confinement and physical distancing are disrupting the methods of psychological support intended for the bereaved. The main community organizations offering group support have had to suspend their activities. Professional individual psychotherapy services can be offered virtually, but pose a certain challenge in terms of accessibility and equity given the costs they generate for bereaved individuals whose job security is often affected. In April 2020, our team benefited from a start-up grant to set up the "I accompany" project; a participatory action research project developed using the compassionate communities approach. These funds allowed us to gather empirical data through in-depth qualitative interviews with 13 participants bereaved by the consequences of COVID-19 and thus better understand their support needs. As part of this request, we wish to: continue and deepen our understanding of grief in the context of a pandemic by increasing the size of our sample, add a longitudinal component by documenting the evolution of the grieving process of these participants in order to identify the factors that may contribute to possible complications of bereavement and document the effectiveness of an alternative and accessible virtual support modality for bereaved people in the context of the pandemic.]

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Development and Validation of the Intimate Partner Violence Workplace Disruptions Assessment (IPV-WDA).

Elucidating directed neural dynamics of scene construction across memory and imagination

Implementing a Novel Resident-Led Peer Support Program for Emergency Medicine Resident Physicians.

Cross-Activity Analysis of CRISPR/Cas9 Editing in Gene Families of <i>Solanum lycopersicum</i> Detected by Long-Read Sequencing.

Creating health systems citizens: enhanced professional identity formation through a para-curricular distinction track in health systems transformation and leadership.

A Comparison of Clinical Diagnostic Classification Criteria Used in Longitudinal Cohort Studies of the Alzheimer's Disease Continuum: A Systematic Review.

Identification and Characterization of a Rare Exon 22 Duplication in <i>CFTR</i> in Two Families.

Structural Rearrangement in Cyclic Cu(II) Pyridyltriazole Complexes: Oxidation of Dabco to Oxalate and CO<sub>2</sub> Conversion to Carbonate.

Administration of FOLFIRINOX for Advanced Pancreatic Cancer: Physician Practice Patterns During Early Use.